Evidence map›Paper›PMID 38724734›Full record

ArticleNature aging2024

Converting cell death into senescence by PARP1 inhibition improves recovery from acute oxidative injury.

Jamil Nehme, Lina Mesilmany, Marta Varela-Eirin, Simone Brandenburg, Abdullah Altulea, Yao Lin, Mariana Gaya da Costa, Marc Seelen, Jan-Luuk Hillebrands, Harry van Goor and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jamil NehmeEuropean Research Institute for the Biology of Ageing (ERIBA), University of Groningen (RUG), University Medical Center Groningen, Groningen, the Netherlands.ORCID http://orcid.org/0000-0003-2771-2043
Lina MesilmanyDepartment of Biology, Lebanese University, Beirut, Lebanon.ORCID http://orcid.org/0000-0003-2930-115X
Marta Varela-EirinEuropean Research Institute for the Biology of Ageing (ERIBA), University of Groningen (RUG), University Medical Center Groningen, Groningen, the Netherlands.
Simone BrandenburgEuropean Research Institute for the Biology of Ageing (ERIBA), University of Groningen (RUG), University Medical Center Groningen, Groningen, the Netherlands.
Abdullah AltuleaEuropean Research Institute for the Biology of Ageing (ERIBA), University of Groningen (RUG), University Medical Center Groningen, Groningen, the Netherlands.
Yao LinEuropean Research Institute for the Biology of Ageing (ERIBA), University of Groningen (RUG), University Medical Center Groningen, Groningen, the Netherlands.
Mariana Gaya da CostaDepartment of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Marc SeelenDepartment of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Jan-Luuk HillebrandsDepartment of Pathology & Medical Biology, Pathology Division, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Harry van GoorDepartment of Pathology & Medical Biology, Pathology Division, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Raya SaabDepartment of Pediatrics, Stanford University, Stanford, CA, USA.
Haidar AklDepartment of Biology, Lebanese University, Beirut, Lebanon.ORCID http://orcid.org/0000-0003-4015-6870
Natacha PrevarskayaUniversité de Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Lille, France.
Valerio FarfarielloUniversité de Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Lille, France.ORCID http://orcid.org/0000-0003-3918-0793
Marco DemariaEuropean Research Institute for the Biology of Ageing (ERIBA), University of Groningen (RUG), University Medical Center Groningen, Groningen, the Netherlands. m.demaria@umcg.nl.ORCID http://orcid.org/0000-0002-8429-4813

Funding

KWF Kankerbestrijding (Dutch Cancer Society) 10989
6 · The paper itself

Abstract

Excessive amounts of reactive oxygen species (ROS) lead to macromolecular damage and high levels of cell death with consequent pathological sequelae. We hypothesized that switching cell death to a tissue regenerative state could potentially improve the short-term and long-term detrimental effects of ROS-associated acute tissue injury, although the mechanisms regulating oxidative stress-induced cell fate decisions and their manipulation for improving repair are poorly understood. Here, we show that cells exposed to high oxidative stress enter a poly (ADP-ribose) polymerase 1 (PARP1)-mediated regulated cell death, and that blocking PARP1 activation promotes conversion of cell death into senescence (CODIS). We demonstrate that this conversion depends on reducing mitochondrial Ca2

Indexed as

Cell DeathCellular SenescenceOxidative StressPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsAnimalsCalciumDisease Models, AnimalHumansMiceMitochondriaReactive Oxygen SpeciesReperfusion InjuryCalciumParp1 protein, mousePoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsReactive Oxygen Species

Identifiers

PMID38724734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.